Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ban

Showing results (31-40 of 362) with videos related to

Pageof 37
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 15, 2004
Neuropsychopharmacology and the genetics of schizophrenia: a history of the diagnosis of schizophreniaThomas A Ban
Activitas Nervosa Superior|July 1, 1979
Psychopharmacology in the secondary and tertiary prevention of mental illnessT A Ban
Psychosomatics|September 1, 1973
Haloperidol and the butyrophenonesT A Ban
International Pharmacopsychiatry|January 1, 1974
Negative findings with nicotinic acid in the treatment of schizophreniasT A Ban
Canadian Psychiatric Association Journal|October 1, 1971
Nicotinic acid and psychiatryT A Ban
Psychosomatics|December 1, 1978
Psychopharmacology and psychosomatic disordersT A Ban
Psychopharmacology Bulletin|July 1, 1979
Amoxapine and viloxazine: review of the literature with special reference to clinical studiesT A Ban
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1987
Prolegomenon to the clinical prerequisite: psychopharmacology and the classification of mental disordersT A Ban
Diseases of the Nervous System|November 1, 1975
Clinical psychopharmacology and psychiatryT A Ban
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2006
Academic psychiatry and the pharmaceutical industryThomas A Ban
Pageof 37

Showing results (31-40 of 362) with videos related to

Sort By:
Pageof 37
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 15, 2004
Neuropsychopharmacology and the genetics of schizophrenia: a history of the diagnosis of schizophreniaThomas A Ban
Activitas Nervosa Superior|July 1, 1979
Psychopharmacology in the secondary and tertiary prevention of mental illnessT A Ban
Psychosomatics|September 1, 1973
Haloperidol and the butyrophenonesT A Ban
International Pharmacopsychiatry|January 1, 1974
Negative findings with nicotinic acid in the treatment of schizophreniasT A Ban
Canadian Psychiatric Association Journal|October 1, 1971
Nicotinic acid and psychiatryT A Ban
Psychosomatics|December 1, 1978
Psychopharmacology and psychosomatic disordersT A Ban
Psychopharmacology Bulletin|July 1, 1979
Amoxapine and viloxazine: review of the literature with special reference to clinical studiesT A Ban
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1987
Prolegomenon to the clinical prerequisite: psychopharmacology and the classification of mental disordersT A Ban
Diseases of the Nervous System|November 1, 1975
Clinical psychopharmacology and psychiatryT A Ban
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2006
Academic psychiatry and the pharmaceutical industryThomas A Ban
Pageof 37